Literature DB >> 18316465

Views on data use, confidentiality and consent in a predictive screening involving children.

G Helgesson1, U Swartling.   

Abstract

Data from the 5-6 year control questionnaire of the ABIS study, a Swedish prospective screening of children for Type 1 diabetes, indicates a genuine trust in the researchers--very few participating families expressed concern about their participation. Nevertheless, a majority do not want their research data to be used beyond the agreement of the original consent. They want to be asked for renewed consent in such cases. A vast majority also want potential high-risk information about their child to be communicated to them. Most participating families want this regardless of whether any preventive treatment is available. Although potential benefits for their child is a motivation for participation for a majority of the respondents, they also claim to be motivated by altruistic reasons. These results are compared to results from two similar studies in the UK.

Entities:  

Mesh:

Year:  2008        PMID: 18316465     DOI: 10.1136/jme.2006.020016

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  9 in total

1.  The value of using top-down and bottom-up approaches for building trust and transparency in biobanking.

Authors:  Eric M Meslin
Journal:  Public Health Genomics       Date:  2010-04-15       Impact factor: 2.000

2.  Parental views on informed consent for expanded newborn screening.

Authors:  Louise Moody; Kubra Choudhry
Journal:  Health Expect       Date:  2011-08-12       Impact factor: 3.377

Review 3.  Psychological impact of screening and prediction in type 1 diabetes.

Authors:  Suzanne Bennett Johnson
Journal:  Curr Diab Rep       Date:  2011-10       Impact factor: 4.810

4.  Psychometric properties of the Pediatric Testing Attitudes Scale-Diabetes (P-TAS-D) for parents of children undergoing predictive risk screening.

Authors:  Kenneth P Tercyak; Darren Mays; Suzanne Bennett Johnson; Johnny Ludvigsson; Ulrica Swartling
Journal:  Pediatr Diabetes       Date:  2013-06-14       Impact factor: 4.866

5.  Experience, knowledge, and opinions about childhood genetic testing in Batten disease.

Authors:  Heather R Adams; Katherine Rose; Erika F Augustine; Jennifer M Kwon; Elisabeth A deBlieck; Frederick J Marshall; Amy Vierhile; Jonathan W Mink; Martha A Nance
Journal:  Mol Genet Metab       Date:  2013-11-04       Impact factor: 4.797

6.  Behavioral Science Research Informs Bioethical Issues in the Conduct of Large-Scale Studies of Children's Disease Risk.

Authors:  Kenneth P Tercyak; Ulrica Swartling; Darren Mays; Suzanne Bennett Johnson; Johnny Ludvigsson
Journal:  AJOB Prim Res       Date:  2013-01-01

7.  Clinicians' views and experiences of offering two alternative consent pathways for participation in a preterm intrapartum trial: a qualitative study.

Authors:  Celine Y Chhoa; Alexandra Sawyer; Susan Ayers; Angela Pushpa-Rajah; Lelia Duley
Journal:  Trials       Date:  2017-04-26       Impact factor: 2.279

8.  Parental Estimation of Their Child's Increased Type 1 Diabetes Risk During the First 2 Years of Participation in an International Observational Study: Results From the TEDDY study.

Authors:  Ulrica Swartling; Kristian Lynch; Laura Smith; Suzanne Bennett Johnson
Journal:  J Empir Res Hum Res Ethics       Date:  2016-05-30       Impact factor: 1.978

9.  Exclusive breastfeeding of Swedish children and its possible influence on the development of obesity: a prospective cohort study.

Authors:  Karina Huus; Jonas F Ludvigsson; Karin Enskär; Johnny Ludvigsson
Journal:  BMC Pediatr       Date:  2008-10-09       Impact factor: 2.125

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.